Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Current Pharmaceutical Design
|
October 9, 2002
BAY 43-9006: preclinical data
Scott Wilhelm, Du-Shieng Chien
Clinical & Experimental Metastasis
|
October 4, 2003
Activity of biphenyl matrix metalloproteinase inhibitor BAY 12-9566 in a human breast cancer orthotopic model
Shinichi Nozaki, Sean Sissons, Du-Shieng Chien, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
November 5, 2017
Comparison of glutathione peroxidase-3 protein expression and enzyme bioactivity in normal subjects and patients with sepsis
Wei-Ju Lee, Yen-Ling Chen, Yi-Wen Chu, et al.
Phytochemical Analysis : PCA
|
November 13, 2007
High-performance liquid chromatography-electrospray mass spectrometry for the simultaneous determination of multiple active components in Sheng-Mai San, a prescription of traditional Chinese medicine
Yi-Wei Chang, Hsien-Tsung Yao, Du-Shieng Chien, et al.
Medicine
|
June 3, 2020
Costs and length of sepsis-related hospitalizations in Taiwan
Yen-Jung Chen, Fu-Lun Chen, Jin-Hua Chen, et al.
Pathology Oncology Research : POR
|
February 12, 2026
Commentary: CVM-1118 (foslinanib), a 2-phenyl-4-quinolone derivative, promotes apoptosis and inhibits vasculogenic mimicry via targeting TRAP1
Mary J C Hendrix, Elisabeth A Seftor, Richard E B Seftor, et al.
Pharmacology & Therapeutics
|
January 26, 2016
Tumor cell vascular mimicry: Novel targeting opportunity in melanoma
Mary J C Hendrix, Elisabeth A Seftor, Richard E B Seftor, et al.
Medicine
|
May 18, 2019
Epidemiology of sepsis in Taiwan
Yen-Jung Chen, Fu-Lun Chen, Jin-Hua Chen, et al.
Pathology Oncology Research : POR
|
June 23, 2023
CVM-1118 (foslinanib), a 2-phenyl-4-quinolone derivative, promotes apoptosis and inhibits vasculogenic mimicry via targeting TRAP1
Lifen Shen, Yen-Ling Chen, Chu-Chun Huang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 30, 2008
Identification and characterization of NDT 9513727 [N,N-bis(1,3-benzodioxol-5-ylmethyl)-1-butyl-2,4-diphenyl-1H-imidazole-5-methanamine], a novel, orally bioavailable C5a receptor inverse agonist
Robbin M Brodbeck, Daniel N Cortright, Andrzej P Kieltyka, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Current Pharmaceutical Design
|
October 9, 2002
BAY 43-9006: preclinical data
Scott Wilhelm, Du-Shieng Chien
Clinical & Experimental Metastasis
|
October 4, 2003
Activity of biphenyl matrix metalloproteinase inhibitor BAY 12-9566 in a human breast cancer orthotopic model
Shinichi Nozaki, Sean Sissons, Du-Shieng Chien, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
November 5, 2017
Comparison of glutathione peroxidase-3 protein expression and enzyme bioactivity in normal subjects and patients with sepsis
Wei-Ju Lee, Yen-Ling Chen, Yi-Wen Chu, et al.
Phytochemical Analysis : PCA
|
November 13, 2007
High-performance liquid chromatography-electrospray mass spectrometry for the simultaneous determination of multiple active components in Sheng-Mai San, a prescription of traditional Chinese medicine
Yi-Wei Chang, Hsien-Tsung Yao, Du-Shieng Chien, et al.
Medicine
|
June 3, 2020
Costs and length of sepsis-related hospitalizations in Taiwan
Yen-Jung Chen, Fu-Lun Chen, Jin-Hua Chen, et al.
Pathology Oncology Research : POR
|
February 12, 2026
Commentary: CVM-1118 (foslinanib), a 2-phenyl-4-quinolone derivative, promotes apoptosis and inhibits vasculogenic mimicry via targeting TRAP1
Mary J C Hendrix, Elisabeth A Seftor, Richard E B Seftor, et al.
Pharmacology & Therapeutics
|
January 26, 2016
Tumor cell vascular mimicry: Novel targeting opportunity in melanoma
Mary J C Hendrix, Elisabeth A Seftor, Richard E B Seftor, et al.
Medicine
|
May 18, 2019
Epidemiology of sepsis in Taiwan
Yen-Jung Chen, Fu-Lun Chen, Jin-Hua Chen, et al.
Pathology Oncology Research : POR
|
June 23, 2023
CVM-1118 (foslinanib), a 2-phenyl-4-quinolone derivative, promotes apoptosis and inhibits vasculogenic mimicry via targeting TRAP1
Lifen Shen, Yen-Ling Chen, Chu-Chun Huang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 30, 2008
Identification and characterization of NDT 9513727 [N,N-bis(1,3-benzodioxol-5-ylmethyl)-1-butyl-2,4-diphenyl-1H-imidazole-5-methanamine], a novel, orally bioavailable C5a receptor inverse agonist
Robbin M Brodbeck, Daniel N Cortright, Andrzej P Kieltyka, et al.
Page
of 2